Camlin Fine Sciences
CAMLINFINE •NSE

Camlin Fine Sciences

₹91.382.91 (3.29%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
87.46
Today’s high
93.00
52 week low
78.80
52 week high
201.79
Open price
90.45
Previous close
88.47
Live volume
5,71,493
Lower circuit
70.78
Upper circuit
106.16

Fundamentals

Market Cap
₹1,702Cr
ROE
1.18%
P/E Ratio(TTM)
2953.00
EPS(TTM)
0.03
P/B Ratio
1.64
Dividend Yield
0.00%
Industry P/E
32.26
Book Value
54.01
Debt to Equity
0.69
Face Value
1

Financial performance

Quarterly
Yearly
All Financials
SEP '26
₹496Cr
-4.76%
-₹29.70Cr
+11.66%
-2000200400600
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue growthValue
1Y (TTM)+9%
3Y CAGR+1%
Profit growthValue
1Y (TTM)-50%

About

Headquartered in Mumbai, Camlin Fine Sciences has grown from a small division in 1984 to a major global player in specialty chemicals, shelf-life solutions, and aroma ingredients. Its vision is to be the globally preferred and trusted provider of reliable, innovative specialty ingredients, aroma products, and performance chemicals for customers around the world. The company operates as a vertically integrated provider, which means it controls the manufacturing process from raw materials to the final products for various industries. Its business is structured across three main segments: Specialty Ingredients that extend product freshness, Performance Chemicals for industrial use, and Aroma Ingredients that supply products like vanillin. A key strategic advantage is its in-house production of diphenols, the core ingredient for its antioxidant products, ensuring quality control and stable supply. As a globally recognized leader in antioxidants, the company serves over 1,250 satisfied customers and has a footprint in more than 80 countries.;
CEO/MD
N Momaya
Founded in
1993
NSE symbol
CAMLINFINE
Industry

Shareholding pattern

Nov '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹529.00
+8.45 (1.62%)
L
    H
    26,255.5230.555.11
    ₹439.15
    +10.35 (2.41%)
    L
      H
      15,561.6026.242.48
      AtulATUL
      ₹5,073.00
      +12.50 (0.25%)
      L
        H
        14,934.4818.972.27
        ₹3,271.40
        -17.80 (0.54%)
        L
          H
          12,824.6834.728.14
          Livesquawk •
          Camlin Fine Sciences reported Q2 revenue of ₹4.9B compared to ₹4.6B in the prior year. The quarterly performance reflects positive year-on-year revenue growth.
          Livesquawk •
          Camlin Fine Sciences' Q1 revenue rose to ₹5.2B from ₹4.23B YoY, a 23% increase.
          2026
          3
          Nov
          Quarterly Result
          Today
          Release date
          11
          Aug
          Quarterly Result
          Release date
          26
          May
          Annual Result
          Release date
          13
          Feb
          Quarterly Result
          Release date
          2025
          10
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date

          8
          Jan
          Rights Entitlement
          Ex date
          5:41
          Ratio

          5 rights eligible for every 41 existing shares held
          Ratio5:41
          Offer price₹110.00
          Ex date8 Jan ‘25
          Record date8 Jan ‘25
          Announcement date2 Jan ‘25

          2
          Jan
          Rights Entitlement
          Announced
          5:41
          Ratio

          5 rights eligible for every 41 existing shares held
          Ratio5:41
          Offer price₹110.00
          Ex date8 Jan ‘25
          Record date8 Jan ‘25
          Announcement date2 Jan ‘25
          Events calendar
          View upcoming events in other stocks